Wellington Management Group’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-64,872
Closed -$686K 1976
2025
Q2
$686K Buy
64,872
+7,899
+14% +$99.7K ﹤0.01% 1768
2025
Q1
$856K Buy
56,973
+17,188
+43% +$286K ﹤0.01% 1737
2024
Q4
$655K Buy
39,785
+1,407
+4% +$27.8K ﹤0.01% 1795
2024
Q3
$948K Sell
38,378
-1,904
-5% -$49.4K ﹤0.01% 1721
2024
Q2
$1.02M Buy
40,282
+2,981
+8% +$77.3K ﹤0.01% 1668
2024
Q1
$947K Buy
+37,301
New +$903K ﹤0.01% 1698
2019
Q1
Sell
-133,894
Closed -$4.5M 2028
2018
Q4
$4.5M Sell
133,894
-72,518
-35% -$2.62M ﹤0.01% 1420
2018
Q3
$8.71M Sell
206,412
-176,586
-46% -$6.98M ﹤0.01% 1329
2018
Q2
$12.3M Sell
382,998
-666,095
-63% -$27.4M ﹤0.01% 1220
2018
Q1
$52.2M Sell
1,049,093
-162,585
-13% -$9.19M 0.01% 759
2017
Q4
$65.3M Sell
1,211,678
-14,393
-1% -$797K 0.01% 689
2017
Q3
$71.1M Buy
1,226,071
+19,748
+2% +$1.03M 0.02% 650
2017
Q2
$59.5M Buy
1,206,323
+79,993
+7% +$3.68M 0.01% 678
2017
Q1
$48.9M Buy
1,126,330
+6,373
+0.6% +$304K 0.01% 732
2016
Q4
$54.8M Sell
1,119,957
-10,250
-0.9% -$474K 0.01% 692
2016
Q3
$54.1M Buy
1,130,207
+11,810
+1% +$583K 0.01% 670
2016
Q2
$60M Buy
1,118,397
+8,221
+0.7% +$387K 0.02% 627
2016
Q1
$49.6M Sell
1,110,176
-79,959
-7% -$3.24M 0.01% 682
2015
Q4
$45.4M Sell
1,190,135
-102,487
-8% -$3.92M 0.01% 697
2015
Q3
$41.1M Buy
1,292,622
+436,514
+51% +$15.2M 0.01% 737
2015
Q2
$28.3M Sell
856,108
-5,238
-0.6% -$187K 0.01% 898
2015
Q1
$35.5M Buy
861,346
+21,212
+3% +$858K 0.01% 842
2014
Q4
$34.2M Buy
840,134
+322,897
+62% +$12.6M 0.01% 854
2014
Q3
$19M Buy
517,237
+127,905
+33% +$5.53M 0.01% 1040
2014
Q2
$18M Buy
389,332
+73,700
+23% +$3.28M ﹤0.01% 1072
2014
Q1
$13M Buy
315,632
+115,022
+57% +$4.28M ﹤0.01% 1171
2013
Q4
$7.66M Sell
200,610
-128,268
-39% -$3.96M ﹤0.01% 1332
2013
Q3
$7.88M Sell
328,878
-343,300
-51% -$7.71M ﹤0.01% 1284
2013
Q2
$11.4M Buy
+672,178
New +$9.7M ﹤0.01% 1140

Other funds holding ANIK